Who are Novo Nordisk's investors?

Novo Nordisk's investors include HM Venture Partners, Novo Holdings.

Where is Novo Nordisk headquartered?

Novo Nordisk is headquartered in Copenhagen, DK.

Novo Nordisk

Copenhagen, DK · Founded 1923 · 62,246 employees on LinkedIn · 2 known investors

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.

Biotech Healthtech

Founders & leadership

Maziar Mike Doustdarin

Investors · 2

HM Venture PartnersSan Francisco

Novo HoldingsCopenhagen · $1.1M – $54M

Founder mafia

3 people who came through Novo Nordisk went on to found or lead other companies.

Jan Møller MikkelsenManager, Enzyme StructureFounded Ascendis Pharma Quin WillsHead of Cellular and Systems Genomics, Novo Nordisk Research Centre OxfordFounded Ochre Bio Sebastian BitschEngineer in Advanced Robotics @ Aseptic ManufacturingFounded Rencom

Competitors · 2

by search overlap

Ro938 shared keywordsRo is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.

Medscape867 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Novo Nordisk for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 3

Early investors' stakes continue via these deals

Forma Therapeutics

Clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare hematologic diseases and cancers, acquired by Novo Nordisk in 2022.

Inversago

Portfolio company acquired by Novo Nordisk for $1.1B USD.

KBP

Hypertension company acquired by Novo Nordisk.

Frequently asked questions

What does Novo Nordisk do?: Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.
Who are Novo Nordisk's investors?: Novo Nordisk's investors include HM Venture Partners, Novo Holdings.
Where is Novo Nordisk headquartered?: Novo Nordisk is headquartered in Copenhagen, DK.